Technical Analysis for NVO - Novo Nordisk A/S

Grade Last Price % Change Price Change
B 74.15 -0.11% -0.08
NVO closed down 0.11 percent on Thursday, April 22, 2021, on 69 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical NVO trend table...

Date Alert Name Type % Chg
Stochastic Sell Signal Bearish 0.00%
Cup with Handle Other 0.00%
Doji - Bearish? Reversal 0.00%
Upper Bollinger Band Walk Strength 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Upper Bollinger Band Walk Strength -0.11%
Above Upper BB Strength -0.11%
Overbought Stochastic Strength -0.11%
Up 3 Days in a Row Strength -0.11%
Older End-of-Day Signals for NVO ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Novo Nordisk A/S Description

Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. The Diabetes Care segment covers insulins, GLP-1 analog, obesity, and oral antidiabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth hormone therapy, hormone replacement therapy, and inflammation. The company sells its products primarily in North America, China, Japan, Algeria, Argentina, Australia, Brazil, India, Turkey, and European countries through its subsidiaries, distributors, and independent agents. Novo Nordisk A/S was founded in 1925 and is headquartered in Bagsvaerd, Denmark.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Life Sciences Diabetes Pharmaceutical Products Inflammation Endocrine System Insulin Hormones Obesity Biopharmaceuticals Peptide Hormones Growth Hormone Glucagon Like Peptide 1 Pharmaceuticals Segment Anti Diabetic Drugs Diabetes Care Growth Hormone Therapy Haemophilia Hormone Therapy Novo Nordisk Related Delivery Systems

Is NVO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 75.8601
52 Week Low 61.53
Average Volume 945,717
200-Day Moving Average 69.16
50-Day Moving Average 71.08
20-Day Moving Average 69.96
10-Day Moving Average 71.89
Average True Range 1.07
ADX 20.64
+DI 39.74
-DI 17.32
Chandelier Exit (Long, 3 ATRs ) 71.29
Chandelier Exit (Short, 3 ATRs ) 69.81
Upper Bollinger Band 74.50
Lower Bollinger Band 65.41
Percent B (%b) 0.96
BandWidth 13.00
MACD Line 0.92
MACD Signal Line 0.26
MACD Histogram 0.6688
Fundamentals Value
Market Cap 171.61 Billion
Num Shares 2.31 Billion
EPS 2.46
Price-to-Earnings (P/E) Ratio 30.12
Price-to-Sales 7.68
Price-to-Book 16.16
PEG Ratio 2.82
Dividend 1.04
Dividend Yield 1.40%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 75.12
Resistance 3 (R3) 75.13 74.82 74.96
Resistance 2 (R2) 74.82 74.57 74.82 74.91
Resistance 1 (R1) 74.49 74.42 74.33 74.47 74.85
Pivot Point 74.17 74.17 74.09 74.17 74.17
Support 1 (S1) 73.84 73.93 73.68 73.83 73.45
Support 2 (S2) 73.52 73.77 73.52 73.39
Support 3 (S3) 73.19 73.52 73.34
Support 4 (S4) 73.18